FdaApplication
ANDA 219119
Identifiers
- fda_app_no: ANDA219119
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2026-01-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION;ORAL |
1 product